Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Next Previous
Trial Profile

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Acronyms ARTEMIS
  • Sponsors AstraZeneca

Most Recent Events

  • 18 Nov 2019 Results (n=6135) assessing copayment assistance interventions utilized when available and their impact on medication persistence were presented at the American Heart Association Scientific Sessions 2019
  • 01 Jan 2019 Results assessing the co-payments impact on P2Y12 inhibitor use and major cardiovascular events published in the JAMA: the Journal of the American Medical Association
  • 14 Nov 2018 Results assessing the "Halo Effect" of a P2Y12 Inhibitor Copayment Reduction Intervention on Persistence and Adherence With Other Secondary Prevention Medications, presented at the 91st Annual Scientific Sessions of the American Heart Association

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top